Abstract 3465: Context-dependent effects of ATRX loss on telomere biology in glioma cellsJacqueline A. Brosnan‐Cashman, Alan K. Meeker, Anthony Rizzo et al.|Cancer Research|2017Cited by 0
Abstract 3466: ALT-positive pediatric high grade glioma cells display chemosensitivity to ATR pathway inhibitionJacqueline A. Brosnan‐Cashman, Alan K. Meeker, Reza Zarinshenas et al.|Cancer Research|2017Cited by 0
PDCT-02. COMBINED INHIBITION OF MTORC1/C2 AND MEK PATHWAY IS SYNERGISTIC IN PRECLINICAL TESTING OF PEDIATRIC LOW-GRADE GLIOMA INCLUDING A NOVEL PATIENT-DERIVED NF1 PILOCYTIC ASTROCYTOMA CELL LINEAntje Arnold, Eric H. Raabe, Charles G. Eberhart et al.|Neuro-Oncology|2018Cited by 0
PDTM-18. COMBINED SUPPRESSION OF THE mTOR AND MAPK PATHWAYS INHIBITS GROWTH, DECREASES VASCULARITY AND INDUCES APOPTOSIS OR SENESCENCE IN PEDIATRIC LOW GRADE GLIOMAAntje Arnold, Eric H. Raabe, Charles G. Eberhart et al.|Neuro-Oncology|2019Cited by 0